DNA topoisomerase II α expression is associated with alkylating agent resistance
EDER, J. P, CHAN, V. T.-W, SHU-WING NG, NAIYER, N. A, ZACHAROULIS, S, TEICHER, B. A, SCHNIPPER, L. E
Published in Cancer research (Chicago, Ill.) (15.12.1995)
Get full text
Published in Cancer research (Chicago, Ill.) (15.12.1995)
Journal Article
Safety and Pharmacokinetics of the Dual Action Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor, BAY 43-9006, in Patients with Advanced, Refractory Solid Tumors
CLARK, Jeffrey W, EDER, Joseph P, RYAN, David, LATHIA, Chetan, LENZ, Heinz-Josef
Published in Clinical cancer research (01.08.2005)
Published in Clinical cancer research (01.08.2005)
Get full text
Journal Article
Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells
J P Eder, Jr, V T Chan, E Niemierko, B A Teicher, L E Schnipper
Published in The Journal of biological chemistry (05.07.1993)
Published in The Journal of biological chemistry (05.07.1993)
Get full text
Journal Article
Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily
EDER, Joseph P, SUPKO, Jeffrey G, CONNORS, Susan, KEOGAN, Mary T, JANICEK, Milos J, FOGLER, William E, SCHNIPPER, Lowell, KINCHLA, Nancy, SIDOR, Carolyn, PHILLIPS, Eric, FOLKMAN, Judah, KUFE, Donald W, CLARK, Jeffrey W, PUCHALSKI, Thomas A, GARCIA-CARBONERO, Rocio, RYAN, David P, SHULMAN, Lawrence N, PROPER, Joann, KIRVAN, Moira, RATTNER, Barbara
Published in Journal of clinical oncology (15.09.2002)
Published in Journal of clinical oncology (15.09.2002)
Get full text
Journal Article
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells
SCHUCH, Gunter, HEYMACH, John V, NOMI, Masashi, MACHLUF, Marcelle, FORCE, Jeremy, ATALA, Anthony, EDER, Joseph P, FOLKMAN, Judah, SOKER, Shay
Published in Cancer research (Chicago, Ill.) (01.12.2003)
Get full text
Published in Cancer research (Chicago, Ill.) (01.12.2003)
Journal Article
A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer
Eder, J P, Kantoff, P W, Roper, K, Xu, G X, Bubley, G J, Boyden, J, Gritz, L, Mazzara, G, Oh, W K, Arlen, P, Tsang, K Y, Panicali, D, Schlom, J, Kufe, D W
Published in Clinical cancer research (01.05.2000)
Get full text
Published in Clinical cancer research (01.05.2000)
Journal Article
Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle
HAMILTON, A. L, EDER, J. P, KINCHLA, N, BOYDEN, J, YEE, H, ZELENIUCH-JACQUOTTE, A, WRIGHT, J, ELLIOTT, P, ADAMS, J, MUGGIA, F. M, PAVLICK, A. C, CLARK, J. W, LIEBES, L, GARCIA-CARBONERO, R, CHACHOUA, A, RYAN, D. P, SOMA, V, FARRELL, K
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC‐EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
Caimi, P.F., Eder, J.P., Jacobsen, E.D., Jacobson, C.A., LaCasce, A.S., Shipp, M.A., Chapuy, B., Labriola‐Tomphins, E., Boisserie, F., Passe, S., Chesné, E., Pierceall, W., Zhi, J., DeMario, M., Vaishampayan, U., Dowlati, A., Shapiro, G.I., Fisher, D.C., Armand, P.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously on Days 1, 3, and 5 Every 3 Weeks in Patients with Advanced Solid Tumors
CUNNINGHAM, Casey, APPLENIAN, Leonard J, WEITMAN, Steve, HAMMOND, Lisa A, EDER, Joseph P, KIRVAN-VISOVATTI, Miora, RYAN, David P, REGAN, Eileen, VUKELJA, Svetislava, BONATE, Peter L, RUVUNA, Francis, FRAM, Robert J, JEKUNEN, Antti
Published in Clinical cancer research (01.11.2005)
Published in Clinical cancer research (01.11.2005)
Get full text
Journal Article
Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer
John R. Goffin, Ian C. Anderson, Jeffrey G. Supko, Joseph Paul Eder, Jr, Geoffrey I. Shapiro, Thomas J. Lynch, Margaret Shipp, Bruce E. Johnson, Arthur T. Skarin
Published in Clinical cancer research (01.05.2005)
Published in Clinical cancer research (01.05.2005)
Get full text
Journal Article
Phase I Clinical Trial of the Farnesyltransferase Inhibitor BMS-214662 Given as a 1-Hour Intravenous Infusion in Patients with Advanced Solid Tumors
RYAN, David P, EDER, Joseph P, PUCHLASKI, Thomas, SEIDEN, Michael V, LYNCH, Thomas J, FUCHS, Charles S, AMREIN, Philip C, SONNICHSEN, Darrell, SUPKO, Jeffrey G, CLARK, Jeffrey W
Published in Clinical cancer research (01.04.2004)
Published in Clinical cancer research (01.04.2004)
Get full text
Journal Article
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy
Antman, K, Ayash, L, Elias, A, Wheeler, C, Hunt, M, Eder, J P, Teicher, B A, Critchlow, J, Bibbo, J, Schnipper, L E
Published in Journal of clinical oncology (01.01.1992)
Published in Journal of clinical oncology (01.01.1992)
Get more information
Journal Article
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies
Eder, Jr, Joseph P, Garcia-Carbonero, Rocio, Clark, Jeffrey W, Supko, Jeffrey G, Puchalski, Thomas A, Ryan, David P, Deluca, Pamela, Wozniak, Antoinette, Campbell, Angela, Rothermel, John, LoRusso, Patricia
Published in Investigational new drugs (01.04.2004)
Published in Investigational new drugs (01.04.2004)
Get full text
Journal Article
Phase I dose‐escalation study of tezacitabine in combination with 5‐fluorouracil in patients with advanced solid tumors
Bendell, Johanna C., Eder, Joseph P., Clark, Jeffrey W., Fidias, Panagiotis, Lynch, Thomas J., Seiden, Michael V., Ryan, David P.
Published in Cancer (01.05.2005)
Published in Cancer (01.05.2005)
Get full text
Journal Article
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors
EDER, Joseph P, RYAN, David P, SUPKO, Jeffrey G, APPLEMAN, Leonard, ZHU, Andrew X, PUCHALSKI, Thomas, XIAOYING HE, SONNICHSEN, Daryl S, COOPER, Michael, WRIGHT, John, CLARK, Jeffrey W
Published in Cancer chemotherapy and pharmacology (01.07.2006)
Published in Cancer chemotherapy and pharmacology (01.07.2006)
Get full text
Journal Article
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response
Ayash, L J, Wright, J E, Tretyakov, O, Gonin, R, Elias, A, Wheeler, C, Eder, J P, Rosowsky, A, Antman, K, Frei, 3rd, E
Published in Journal of clinical oncology (01.06.1992)
Published in Journal of clinical oncology (01.06.1992)
Get more information
Journal Article
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours
PENSON, R. T, SEIDEN, M. V, MATULONIS, U. A, APPLEMAN, L. J, FULLER, A. F, GOODMAN, A, CAMPOS, S. M, CLARK, J. W, ROCHE, M, EDER, J. P
Published in British journal of cancer (11.07.2005)
Published in British journal of cancer (11.07.2005)
Get full text
Journal Article
A Phase I Clinical Trial of Sequentially Administered Doxorubicin and Topotecan in Refractory Solid Tumors
SEIDEN, Michael V, NG, Shu-Wing, SUPKO, Jeffrey G, RYAN, David P, CLARK, Jeffrey W, LYNCH, Thomas, HUANG, Kuan-Chun, KWIATKOWSKI, David, SKARIN, Arthur, EDER, Joseph P
Published in Clinical cancer research (01.03.2002)
Get full text
Published in Clinical cancer research (01.03.2002)
Journal Article
Phase I Clinical Trial and Pharmacokinetic Study of the Spicamycin Analog KRN5500 Administered as a 1-Hour Intravenous Infusion for Five Consecutive Days to Patients with Refractory Solid Tumors
SUPKO, Jeffrey G, EDER, Joseph P, RYAN, David P, SEIDEN, Michael V, LYNCH, Thomas J, AMREIN, Phillip C, KUFE, Donald W, CLARK, Jeffrey W
Published in Clinical cancer research (01.11.2003)
Get full text
Published in Clinical cancer research (01.11.2003)
Journal Article